jrnls.org logo
Submit

BROWSE ALL JOURNALS

SEE ALL 19 JOURNALS
Journal of Young PharmacistsNOW IN
Review

Exploring the Data Integrity Ordinance in Pharmaceutical Domain

Darshil B Shah1★, Jignesh S Shah2, Dilip G Maheshwari1★ Corresponding author

  1. 1Department of Quality Assurance, L J Institute of Pharmacy, LJ University, Ahmedabad, Gujarat, INDIA.
  2. 2Department of Regulatory Affairs, L J Institute of Pharmacy, LJ University, Ahmedabad, Gujarat, INDIA.

CORRESPONDENCE

Darshil B Shah

Department of Quality Assurance, L J Institute of Pharmacy, LJ University, Ahmedabad, Gujarat, INDIA.

darshil.shah@ljinstitutes.edu.in

Received: 20-06-2022; Revised: 04-07-2022; Accepted: 27-08-2022.

Volume 14, Issue 4 · pp. 377–381 · PUBLISHED · DOI: 10.5530/jyp.2022.14.76

View on JYP original site ↗

ABSTRACT

With the revolutionary expedition of technologies being used in pharmaceutical world to collect and process data, the honesty of data is predominant factor and subject to preservation. If the data collection of the products soon to be marketed, is adulterated it would not only be a potential harm to general public but also cause of economical and reputational damage for manufacturers. To secure the value of crucial data, regulatory authorities has been producing guidance regarding the integrity of data. Data integrity guarantees that data is not tampered with be it paper or electronic. Protecting the integrity, whether electronic or handwritten, is essential for making sound business decisions. In attempt of introducing aspects of data, the FDA first developed the ALCOA principles which are still the first line defence of integrity breaches in pharmaceutical companies. With the changing times of technologies, FDA evolved the data integrity principles into requirements and specifications of current good manufacturing practice answering questions directly from manufacturers. To understand the basic yet complex terms and conditions, this article strives to outline the Data Integrity requirements of USFDA specified in its cGMP guidance for data integrity specifications

KEYWORDS

Open in new tab

REFERENCES

As published

Showing references and in-text citations exactly as published.

    Cite this article

    SELECT FORMAT

    Shah, D. B., Shah, J. S., & Maheshwari, D. G. (). Exploring the Data Integrity Ordinance in Pharmaceutical Domain. Journal of Young Pharmacists, 14(4), 377–381. https://doi.org/10.5530/jyp.2022.14.76